Possible evidence for human transmission of Alzheimer’s pathology
Publication date: 10 September 2015
Amyloid beta pathology in the grey matter and blood vessel walls characteristic of Alzheimer’s disease (AD) and the related cerebral amyloid angiopathy (CAA) is observed in the brains of deceased patients who acquired Creutzfeldt–Jakob disease (CJD) following treatment with prion-contaminated human growth hormone.
GABA neurotransmitter may be progressive MS marker
Publication date: 4 September 2015
A neurotransmitter widely distributed in the brain may be a marker of a progressive multiple sclerosis, according to research led by Professor Olga Ciccarelli, UCL Institute of Neurology, published in Brain.
Piepenbrock Group and German Center for Neurodegenerative Diseases honour Professor Hardy
Publication date: 17 August 2015
Professor John Hardy, UCL Institute of Neurology, will be awarded this year’s “Hartwig Piepenbrock-DZNE Prize” honouring his seminal contributions to the study of Alzheimer’s disease.
The award ceremony will take place on World Alzheimer's Day, September 21, 2015, in Bonn, Germany.
Professor Hardy has made ground-breaking findings on the molecular causes of this brain disorder. His discoveries provide the basis for therapeutic approaches and potential medicines.